carbazilquinone has been researched along with Esophageal Diseases in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, R | 1 |
| Yamazaki, Y | 1 |
| Shiozaki, K | 1 |
| Akai, S | 1 |
| Shimada, K | 1 |
| Sato, M | 1 |
| Kurita, Y | 1 |
| Hirono, T | 1 |
| Sato, Y | 1 |
1 other study available for carbazilquinone and Esophageal Diseases
| Article | Year |
|---|---|
[An operated case of the lung cancer associated with the esophageal necrosis due to the bronchial artery infusion (author's transl)].
Topics: Antineoplastic Agents; Azirines; Bronchial Arteries; Carbazilquinone; Esophageal Diseases; Esophagop | 1979 |